Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
FASEB J ; 36(11): e22605, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-36250963

RESUMEN

Upon chronic damage to the liver, multiple cytokines stimulate hepatic stellate cells (HSCs), causing the alterations of gene expression profiles and thus leading to HSC activation, a key step in liver fibrogenesis. Activated HSCs are the dominant contributors to liver fibrosis. Bromodomain containing protein 4 (BrD4), an important epigenetic reader, was demonstrated to concentrate on hundreds of enhancers associated with genes involved in multiple profibrotic pathways, thereby directing HSC activation and the fibrotic responses. The present studies were designed to examine the effect of transforming growth factor beta-1 (TGFß1), the most potent pro-fibrotic cytokine, on BrD4 expression in HSCs and, if so, elucidated the underlying mechanisms in vitro and in vivo. The experiments employed the heterogeneous TGFß1 knockout (TGFß1+/- ) mice, gene knockdown in vivo, and a model of thioacetamide (TAA)-induced liver injury. The results revealed that TGFß1 enhanced BrD4 expression in HSCs, which was mediated, at least, by Smad3 signaling and early-immediate gene Egr1 (early growth response-1). TGFß1-induced Smad3 signaling increased Egr1 expression and promoted Egr1 binding to BrD4 promoter at a site around -111 bp, promoting BrD4 expression. Egr1 knockdown reduced BrD4 expression in HSCs in a mouse model of TAA-induced liver injury and lessened liver fibrosis. Double fluorescence staining demonstrated a strong increase in BrD4 expression in activated HSCs in fibrotic areas of the human livers, paralleling the upregulation of p-Smad3 and Egr1. This research suggested novel molecular events underlying the roles of the master pro-fibrotic cytokine TGFß1 in HSC activation and liver fibrogenesis.


Asunto(s)
Enfermedad Hepática Crónica Inducida por Sustancias y Drogas , Proteína 1 de la Respuesta de Crecimiento Precoz , Células Estrelladas Hepáticas , Proteínas Nucleares , Factores de Transcripción , Animales , Humanos , Ratones , Proteínas de Ciclo Celular/genética , Proteínas de Ciclo Celular/metabolismo , Enfermedad Hepática Crónica Inducida por Sustancias y Drogas/metabolismo , Proteína 1 de la Respuesta de Crecimiento Precoz/genética , Proteína 1 de la Respuesta de Crecimiento Precoz/metabolismo , Epigénesis Genética , Fibrosis , Células Estrelladas Hepáticas/metabolismo , Cirrosis Hepática/inducido químicamente , Cirrosis Hepática/genética , Cirrosis Hepática/metabolismo , Proteínas Nucleares/metabolismo , Proteína smad3/genética , Proteína smad3/metabolismo , Tioacetamida/efectos adversos , Factores de Transcripción/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo
2.
ACS Appl Mater Interfaces ; 14(6): 7949-7961, 2022 Feb 16.
Artículo en Inglés | MEDLINE | ID: mdl-35130694

RESUMEN

Cascade reactions take advantage of step-saving and facile operation for obtaining chemicals. Herein, catalytic hydrogenation of nitroarene coupled condensation with ß-diketone to afford ß-ketoenamines is achieved by an integrated nanocatalyst, Pd-e@UiO-66. The catalyst has the structure of an acid-rich metal-organic framework (MOF), UiO-66-encapsulated electron-rich Pd nanoparticles, and it reconciles the electron-effect contradiction of cascade catalytic reactions: catalytic hydrogenation requires an electron-rich catalyst, while condensation requires electron-deficient Lewis acid sites. The catalyst showed good activity, high chemoselectivity, and universal applicability for the synthesis of ß-ketoenamines using nitroarenes. More than 30 ß-ketoenamines have been successfully prepared with up to 99% yield via the methodology of relay catalysis. The catalyst exhibited excellent stability to maintain its catalytic performance for more than five cycles. Furthermore, we conducted an in-depth exploration of the reaction mechanism with theoretical calculations.

3.
J Pathol ; 252(4): 423-432, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32827238

RESUMEN

Obese patients, often accompanied by hyperleptinemia, are prone to develop liver fibrosis. A large body of data including the results from human studies suggested the promotion role of leptin, an adipocyte-derived hormone, in liver fibrosis. Hepatic stellate cell (HSC) activation, a crucial step in liver fibrogenesis, requires global reprogramming of gene expression which is regulated by multiple mechanisms including epigenetic regulation such as methylation of DNA. S-Adenosylmethionine is a principal biological methyl donor and its biosynthesis is catalyzed by a methionine adenosyltransferase (MAT) such as MATII. MATII consists of the catalytic subunit MAT2A and regulatory subunit MAT2B which are essential for HSC activation. The present research investigated the effect of leptin on the expression of Mat2b in HSCs in vitro and in a leptin-deficient mouse model. Results demonstrated that leptin significantly increased Mat2b expression. Leptin-induced Mat2b expression required the PI3K/AKT signaling pathway. c-Jun, a component of activator protein (AP1), was phosphorylated by leptin-induced PI3K/AKT signaling and thus potentiated its binding to the element around -964 bp in the Mat2b promoter. MAT2B was involved in leptin-induced HSC activation and liver fibrosis in a leptin-deficient mouse model. These results might broaden understanding of the mechanisms underlying the liver fibrogenesis in obese patients with hyperleptinemia. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.


Asunto(s)
Células Estrelladas Hepáticas/efectos de los fármacos , Leptina/farmacología , Metionina Adenosiltransferasa/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteínas Proto-Oncogénicas c-jun/metabolismo , Transducción de Señal/efectos de los fármacos , Animales , Células Estrelladas Hepáticas/metabolismo , Cirrosis Hepática/metabolismo , Masculino , Ratones , Ratones Obesos , Obesidad/metabolismo , Fosforilación/efectos de los fármacos , Regiones Promotoras Genéticas/efectos de los fármacos
4.
Chempluschem ; 85(8): 1783-1788, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32808467

RESUMEN

Hydrogenation of nitriles is an efficient and environmentally friendly route to synthesize symmetrical secondary amines, but it usually produces a mixture of amines, imines, and hydrogenolysis by-products. Herein we report a magnetic quaternary-component Pt-CuFe/Fe3 O4 nanocatalyst system for the selective synthesis of symmetrical secondary amines with ammonia borane as hydrogen donor. The catalyst with a low Pt loading (0.456 wt%) is the source of the activity, and the d-band electron transfer from Cu to Fe enhances the selectivity. This synergistic effect results in the transformation of benzonitrile to dibenzylamine with excellent conversion (up to 99 %) and nearly quantitative selectivity (up to 96 %) under mild reaction conditions, nevertheless, the reaction TOF is as high as up to 1409.9 h-1 . A variety of nitriles are suitable for the synthesis of symmetrical secondary amines. More importantly, unwanted hydrogenolysis byproducts, especially toluene, is not detected at all. In addition, the catalyst is magnetically recoverable, and it can be reused up to five times.

5.
J Cell Mol Med ; 24(17): 10063-10074, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32678475

RESUMEN

Sterol regulatory element-binding protein 1c (SREBP1c) plays key roles in maintenance of hepatic stellate cell (HSC) quiescence. The present researches investigated the mechanisms underlying the effects of SREBP1c on HSCs and liver fibrogenesis by HSC-targeted overexpression of the active SREBP1c using adenovirus in vitro and in vivo. Results demonstrated that SREBP1c exerted inhibitory effects on TAA-induced liver fibrosis. SREBP1c down-regulated TGFß1 level in liver, reduced the receptors for TGFß1 and PDGFß, and interrupted the signalling pathways of Smad3 and Akt1/2/3 but not ERK1/2 in HSCs. SREBP1c also led to the decreases in the protein levels of the bromodomain-containing chromatin-modifying factor bromodomain protein 4, methionine adenosyltransferase 2B (MAT2B) and TIMP1 in HSCs. In vivo activated HSCs did not express cyclin D1 and cyclin E1 but SREBP1c down-regulated both cyclins in vitro. SREBP1c elevated PPARγ and MMP1 protein levels in the model of liver fibrosis. The effect of SREBP1c on MAT2B expression was associated with its binding to MAT2B1 promoter. Taken together, the mechanisms underlying the effects of SREBP1c on HSC activation and liver fibrosis were involved in its influences on TGFß1 level, the receptors for TGFß1 and PDGFß and their downstream signalling, and the molecules for epigenetic regulation of genes.


Asunto(s)
Células Estrelladas Hepáticas/metabolismo , Cirrosis Hepática/metabolismo , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/metabolismo , Animales , Células Cultivadas , Regulación hacia Abajo/fisiología , Hígado/metabolismo , Masculino , Metionina Adenosiltransferasa/metabolismo , Ratones , Ratones Endogámicos C57BL , Factor de Crecimiento Derivado de Plaquetas/metabolismo , Regiones Promotoras Genéticas/fisiología , Transducción de Señal/fisiología , Inhibidor Tisular de Metaloproteinasa-1/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo
6.
FASEB J ; 34(4): 5578-5589, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32108965

RESUMEN

Most obese patients develop hyperleptinaemia. Leptin, mainly produced by adipocytes, demonstrates a promotional role in liver fibrosis. Hepatic stellate cell (HSC) activation, a key step in liver fibrogenesis, requires global reprogramming of gene expression. The remodeling of DNA methylation is a mechanism of the epigenetic regulation of gene expression. The biosynthesis of S-adenosylmethionine, a principle biological methyl donor, is catalyzed by methionine adenosyltransferase (MAT) such as MATⅡ which has been shown to promote HSC activation in vitro. This study was mainly aimed to determine the effect of leptin on MAT2A expression (the catalytic subunit of MATⅡ) in HSCs. Results showed that MAT2A knockdown reduced leptin-induced HSC activation and liver fibrosis in the leptin-deficient mouse model. Leptin promoted MAT2A expression in HSCs and increased MAT2A promoter activity. The axis of the ß-catenin pathway/E2F-4 mediated the effect of leptin on MAT2A expression. Leptin-induced ß-catenin signaling reduced E2F-4 expression and thus abated E2F-4 binding to MAT2A promoter at a site around -2779 bp, leading to an increase in the MAT2A promoter activity. These data might shed more light on the mechanisms responsible for liver fibrogenesis in obese patients with hyperleptinaemia.


Asunto(s)
Factor de Transcripción E2F4/antagonistas & inhibidores , Regulación de la Expresión Génica/efectos de los fármacos , Células Estrelladas Hepáticas/patología , Leptina/farmacología , Cirrosis Hepática/patología , Metionina Adenosiltransferasa/metabolismo , beta Catenina/metabolismo , Animales , Factor de Transcripción E2F4/metabolismo , Células Estrelladas Hepáticas/efectos de los fármacos , Células Estrelladas Hepáticas/metabolismo , Cirrosis Hepática/etiología , Cirrosis Hepática/metabolismo , Metionina Adenosiltransferasa/genética , Ratones , Ratones Endogámicos C57BL , Ratones Obesos , Obesidad/fisiopatología , beta Catenina/genética
7.
Chemistry ; 25(29): 7191-7200, 2019 May 23.
Artículo en Inglés | MEDLINE | ID: mdl-30913325

RESUMEN

Facile and large-scale preparation of materials with uniform distributions of ultrafine particles for catalysis is a challenging task, and it is even more difficult to obtain catalysts that excel in both the hydrogen evolution reaction (HER) and hydrogenation, which are the corresponding merging and splitting procedures of hydrogen, respectively. Herein, the fabrication of ultrafine bimetallic PtNi nanoparticles embedded in carbon nanosheets (CNS) by means of in situ self-polymerization and annealing is reported. This bifunctional catalyst shows excellent performance in the hydrogen evolution reaction (HER) and the hydrogenation of p-nitrophenol. Remarkably PtNi bimetallic catalyst with low metal loading (PtNi2 @CNS-600, 0.074 wt % Pt) exhibited outstanding HER activity with an overpotential as low as 68 mV at a current density of 10 mA cm-2 with a platinum loading of only 0.612 µgPt cm-2 and Tafel slope of 35.27 mV dec-1 in a 0.5 m aqueous solution of H2 SO4 , which is comparable to that of the 20 % Pt/C catalyst (31 mV dec-1 ). Moreover, it also shows superior long-term electrochemical durability for at least 30 h with negligible degradation compared with 20 % Pt/C. In addition, the material with increased loading (mPtNi2 @CNS-600, 2.88 % Pt) showed robust catalytic activity for hydrogenation of p-nitrophenol at ambient pressure and temperature. The catalytic activity towards hydrogen splitting is a circumstantial evidence that agrees with the Volmer-Tafel reaction path in the HER.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA